Elevated levels of interleukin-6 (IL-6) during the acute phase have prompted investigations into its role in long-term COVID-19 sequelae [123,124,125], suggesting that persistent inflammation could underlie the pathophysiology of Long COVID. This evidence concerns the gene IL6 and COVID-19.